Premature ejaculation is the most common male sexual dysfunction, affecting an estimated 20-30% of men across all age groups. ( 1 ) Despite its prevalence, it remains one of the most underreported and undertreated conditions in men’s health. Many men either assume nothing can be done, feel too embarrassed to raise it with a physician, or try ineffective approaches purchased online. The reality is that PE is well understood, has multiple effective treatment options, and in most cases responds well to appropriate intervention.
What Is Premature Ejaculation?
Premature ejaculation is clinically defined as ejaculation that occurs within approximately one minute of vaginal penetration, before the person wishes it, and which causes significant distress. ( 2 ) The International Society for Sexual Medicine recognizes two main subtypes: lifelong (primary) PE, which has been present since first sexual experience; and acquired (secondary) PE, which develops after a period of normal ejaculatory function. A third category, natural variable PE, refers to inconsistent early ejaculation that is situational rather than persistent, and is generally not considered a disorder requiring treatment.
The distress component matters clinically. Intravaginal ejaculatory latency time (IELT) varies widely among men, and a short IELT alone does not constitute a disorder if it does not cause personal or relational distress.
How Ejaculatory Control Works (and Why It Fails)
Ejaculation is a spinal reflex coordinated by the lumbar spinal cord, modulated by descending serotonergic pathways from the brain. Serotonin acts as an inhibitory signal on ejaculation: higher serotonergic tone delays ejaculation, while lower tone accelerates it. ( 3 ) Men with lifelong PE appear to have a genetically determined lower serotonergic inhibitory threshold, making the ejaculatory reflex fire more quickly and at lower levels of stimulation. This neurobiological basis explains why serotonergic medications are often effective for PE and why the condition tends to run in families. ( 4 )
In acquired PE, the mechanism is different. Ejaculatory control was once normal, so the question becomes: what changed? Common triggers include new psychological stressors, relationship conflict, comorbid erectile dysfunction, prostatitis, thyroid dysfunction, or hormonal changes.
Causes and Contributing Factors
Neurobiological Factors
As described above, lifelong PE is primarily driven by serotonin pathway hyposensitivity. This is a biological set point, not a psychological failing. ( 5 ) Men with this subtype often report that PE has been present since adolescence and has remained consistent regardless of partner, relationship quality, or stress level.
Psychological and Relational Factors
Anxiety is the most prominent psychological contributor to PE, particularly in acquired cases. Performance anxiety creates a feedback loop: concern about ejaculating quickly increases sympathetic nervous system activation, which accelerates the ejaculatory reflex. ( 6 ) Depression, guilt, and poor self-image also contribute. Relationship dynamics, including communication issues, partner pressure, or conflict, amplify the problem.
Hormonal Factors
Elevated prolactin levels and thyroid dysfunction (both hyper- and hypothyroidism) have been associated with acquired PE in multiple studies. ( 7 ) A 2016 review in the Journal of Sexual Medicine identified hyperthyroidism as a particularly consistent hormonal trigger for acquired PE. Testosterone levels also play a role; in some men, hormonal shifts alter the ejaculatory threshold. If acquired PE appeared alongside other symptoms of hormonal imbalance, evaluation of hormone levels is warranted.
Comorbid Erectile Dysfunction
PE and ED frequently coexist, and the relationship is bidirectional. Men with ED sometimes rush toward ejaculation due to anxiety about losing their erection; this secondary PE then persists even after ED is treated. Identifying which condition is primary and which is secondary changes the treatment approach significantly. ( 8 )
What Actually Works: Evidence-Based Treatments
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs are the most pharmacologically effective treatment for PE due to their direct effect on serotonin availability. Daily dosing produces the most consistent results by maintaining elevated serotonergic tone continuously. A 2017 meta-analysis in the Asian Journal of Andrology confirmed that daily SSRIs significantly increased IELT compared to placebo across multiple study populations. ( 9 ) A short-acting SSRI formulation is also available for on-demand use several hours before sexual activity. These medications require a prescription and should be managed by a physician familiar with both their sexual and systemic effects.
Topical Anesthetics
Topical agents such as lidocaine/prilocaine cream or spray reduce penile hypersensitivity and increase ejaculatory latency without systemic side effects when used correctly. ( 10 ) Application timing and amount matter; excessive use can transfer to a partner and cause numbness, which reduces pleasure for both parties. When used appropriately, topical agents are a practical, accessible option for many men, particularly those who prefer to avoid systemic medication.
Behavioral Techniques
The squeeze technique and the stop-start method are the two most studied behavioral interventions. Both train the man to recognize and modulate pre-ejaculatory arousal levels. ( 11 ) Behavioral techniques alone are less effective for lifelong PE with a strong neurobiological basis, but they add meaningful benefit when combined with pharmacological treatment, especially in acquired PE where anxiety is a primary driver.
Psychotherapy and Couples Therapy
For men whose PE is rooted in anxiety, relational dynamics, or past sexual experiences, sex therapy and cognitive behavioral approaches address the psychological substrate. Therapy is most effective in acquired PE and should be considered when the relationship dimension is a significant contributor to distress. ( 12 )
Common Myths About Premature Ejaculation
Myth: PE is caused by too much masturbation or sexual inexperience. Masturbatory habits have not been shown to cause PE. Lifelong PE is neurobiological in origin. The idea that experience alone fixes it ignores the clinical evidence.
Myth: Thinking about something else during sex helps. Mental distraction is an avoidance strategy that reduces intimacy without improving ejaculatory control. It does not address the underlying mechanism and has no clinical support as a standalone treatment.
Myth: PE is just anxiety and will go away on its own. Anxiety-driven acquired PE can resolve with stress reduction, but lifelong PE does not remit without targeted intervention. Waiting it out rarely works when the cause is neurobiological.
When to See a Doctor
Any man who is consistently distressed by early ejaculation should seek evaluation. Particular triggers for medical evaluation include: PE that developed suddenly after a period of normal function; PE accompanied by other symptoms such as urinary urgency, pelvic discomfort, or signs of hormonal imbalance; or PE that occurs alongside ED. A physician should take a complete sexual and medical history, consider hormonal evaluation including prolactin and thyroid function, and assess for comorbid conditions. This is a treatable condition and there is no medical reason to simply endure it.
Get Evaluated at Modern Men’s Health
Premature ejaculation affects quality of life, relationships, and confidence in a way that compounds over time if left unaddressed. At Modern Men’s Health, we evaluate PE in the context of your complete hormonal and sexual health profile. We check for underlying hormonal contributors, assess for comorbid ED, and develop a treatment approach tailored to whether your PE is primarily neurobiological, psychological, or driven by an identifiable medical trigger. Effective options exist across every category. The first step is a proper diagnosis. Understanding your hormone baseline is often a valuable starting point for men with acquired PE or co-occurring symptoms of hormonal change.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee. Sexual Medicine. 2014;2(2):41-59. https://doi.org/10.1002/sm2.27
- Althof SE, McMahon CG, Waldinger MD, et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. Sexual Medicine. 2014;2(2):60-90. https://doi.org/10.1002/sm2.28
- Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. European Urology. 2006;50(3):454-466. https://doi.org/10.1016/j.eururo.2006.05.055
- Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Journal of Clinical Psychopharmacology. 1998;18(4):274-281. https://doi.org/10.1097/00004714-199808000-00002
- Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007;67(4):547-568. https://doi.org/10.2165/00003495-200767040-00005
- Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man’s life? Journal of Sex & Marital Therapy. 2003;29(5):361-370. https://doi.org/10.1080/00926230390224738
- Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. Journal of Clinical Endocrinology & Metabolism. 2005;90(12):6472-6479. https://doi.org/10.1210/jc.2005-1135
- El-Nashaar A, Shamloul R. Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. Journal of Sexual Medicine. 2007;4(2):491-496. https://doi.org/10.1111/j.1743-6109.2007.00425.x
- Jannini EA, Lenzi A. Epidemiology of premature ejaculation. Current Opinion in Urology. 2005;15(6):399-403. https://doi.org/10.1097/01.mou.0000183886.99893.78
- Dinsmore WW, Hackett G, Goldmeier D, et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU International. 2007;99(2):369-375. https://doi.org/10.1111/j.1464-410X.2006.06583.x
- Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little, Brown; 1970.
- Althof SE. Treatment of rapid ejaculation: psychotherapy, pharmacotherapy, and combined therapy. In: Leiblum SR, ed. Principles and Practice of Sex Therapy. 4th ed. New York: Guilford Press; 2007:212-240.